MedPath

The medicinal efficacy of Elobixibat in chronic constipation with type 2 diabetes mellitus

Not Applicable
Recruiting
Conditions
chronic constipation complicated with type 2 diabetes mellitus
Registration Number
JPRN-UMIN000034632
Lead Sponsor
Department of metabolic medicine, Faculty of Life science, Graduate School of Medical Sciences, Kumamoto University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

Patients meeting the following criteria will be excluded from the study: 1. Patients with infectious disease in acute phase, who had fever, or signs as getting cold 2. Patients who had past histories of surgeries of ileus, or hospitalization by ileus. 3. Patients with the constipation associated with colon cancers, rectul cancers, or resection of colonal polyps, including polypectomy 4. Patients with cardiovascular or cerebrovascular diseases occured within 12 weeks before the registration of this study 5. Patients with hepatic disfunction as the state of B or C in classification of Child-Pugh at the registration of this study 6. Patients with renal disfunction, which eGFR were lower than 30 ml/min/1.73m2 at the registration of this study 7. Patients with severe respiratory diseases,heart failure or arrhythmia. 8. Patients with mental disorder. 9. Patients who are pregnant or might be pregnant 10. Patients whom the physician in charge judges to be unsuitable for any other reason.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath